Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Guelph

$22,000.00

Characterization, modeling and environmental manipulation of mammalian cell culture systems for optimal protein production

FY 2010-11

Summary
Mammalian cell culture comprises a major platform for producing a number of high-value biopharmaceuticals, including enzymes, monoclonal antibodies (MAbs), viral vaccines, hormones and immuno-regulators. The future of the biopharmaceutical industry will rely on the development and enhancement of these mammalian cell culture production systems. Such biologics are produced in relatively small quantities due to the highly specialized culture conditions needed and the susceptibility of the culture to either reduced productivity or significant cell death as a result of slight changes in culture conditions. While earlier generations of biochemical engineers focused on the non-biological aspects of production, such as reactor design, more recent engineering developments have recognized that the greatest potential for enhancing production lies within the animal cells themselves. In this proposal, an important and often neglected aspect of bioprocess development, namely bioprocess optimization is addressed. This proposal deals with the development of a novel optimization strategy for production of therapeutic proteins by mammalian cells. The problem will be addressed by careful modeling and experiments including the manipulation of temperature, metabolites and metabolic pathways, bioreactor operating mode, and rate of traverse through the cell cycle of the organism under consideration. An important goal is the training of graduate students who are well versed in both the biological and the mathematical aspects of bioprocess optimization. ) Ultimately, the objective of the proposed work is to develop a robust strategy for the design of mammalian cell based therapeutic protein processing systems, including media design, bioreactor operation conditions and operating mode. The general strategy to be used can be defined as macro-scale metabolic engineering combined with modeling at the cellular level. The development of highly reproducible animal cell culture systems will have significant impact for many bioindustrial applications beyond the biopharma industry.
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
346131-2007
Name nom
Dutton, Roshni
Department département
Engineering, School of
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2007
Award amount
22000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
4
Committee name en
Chem. & Metallurgical Eng.
Committee name fr
Génies chimique et métal.
Area of application code
1206
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Engineering
Area of application fr
Génie
Research subject code
1802
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Biochemical engineering
Research subject fr
Génie biochimique
Partie
3
Nb partie
4
Application title
Characterization, modeling and environmental manipulation of mammalian cell culture systems for optimal protein production
Keyword
NSERC
Application summary
Mammalian cell culture comprises a major platform for producing a number of high-value biopharmaceuticals, including enzymes, monoclonal antibodies (MAbs), viral vaccines, hormones and immuno-regulators. The future of the biopharmaceutical industry will rely on the development and enhancement of these mammalian cell culture production systems. Such biologics are produced in relatively small quantities due to the highly specialized culture conditions needed and the susceptibility of the culture to either reduced productivity or significant cell death as a result of slight changes in culture conditions. While earlier generations of biochemical engineers focused on the non-biological aspects of production, such as reactor design, more recent engineering developments have recognized that the greatest potential for enhancing production lies within the animal cells themselves. In this proposal, an important and often neglected aspect of bioprocess development, namely bioprocess optimization is addressed. This proposal deals with the development of a novel optimization strategy for production of therapeutic proteins by mammalian cells. The problem will be addressed by careful modeling and experiments including the manipulation of temperature, metabolites and metabolic pathways, bioreactor operating mode, and rate of traverse through the cell cycle of the organism under consideration. An important goal is the training of graduate students who are well versed in both the biological and the mathematical aspects of bioprocess optimization. ) Ultimately, the objective of the proposed work is to develop a robust strategy for the design of mammalian cell based therapeutic protein processing systems, including media design, bioreactor operation conditions and operating mode. The general strategy to be used can be defined as macro-scale metabolic engineering combined with modeling at the cellular level. The development of highly reproducible animal cell culture systems will have significant impact for many bioindustrial applications beyond the biopharma industry.